evidencegaps
Primary study · included by 1 review

Multicenter Retrospective Study of Weekly Cetuximab Plus Paclitaxel for Recurrent or Metastatic Oral Squamous Cell Carcinoma.

Naruse 2021 · Naruse Tomofumi, Yanamoto Souichi, Otsuru Mitsunobu, et al. · Anticancer research · 2021

Included by

Two-year follow-up outcomes of neoadjuvant therapy in oral squamous cell carcinoma: an exploratory systematic review and meta-analysis.
Non-Cochrane · prognostic · 2026 · cited as Naruse 2021 · Reference list 25-34; Table 1; Fig 4-8

The review does not say which of its outcomes this study informs.

1 including review in total.